Megan Daly, Md
Clinical trials sponsored by Megan Daly, Md, explained in plain language.
-
Experimental combo shows promise in Tough-to-Treat lung cancer
Disease control CompletedThis study tested a new combination treatment for people with advanced non-small cell lung cancer that had already been treated. The treatment combined a cancer vaccine (TG4010) with an immunotherapy drug (nivolumab) to help the immune system fight the cancer. The trial included …
Phase: PHASE2 • Sponsor: Megan Daly, MD • Aim: Disease control
Last updated May 26, 2026 09:42 UTC
-
New combo therapy shows promise for inoperable lung cancer patients
Disease control CompletedThis early-stage study tested a combination of an immunotherapy drug (atezolizumab) and precise, high-dose radiation (SBRT) in 20 people with stage I non-small cell lung cancer who could not have surgery. The main goal was to find the safest dose of atezolizumab when given with r…
Phase: PHASE1 • Sponsor: Megan Daly, MD • Aim: Disease control
Last updated May 18, 2026 12:13 UTC